US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Trimb enters into exclusive licensing agreement with Teva for Flux, Decubal and other brands

Stockholm, February 21, 2019 – Trimb Healthcare AB (“Trimb”) has entered into an exclusive licensing agreement with Teva in Scandinavia for a portfolio of established OTC brands. The products include Flux, a market-leading brand in fluoride rinse, Decubal, a leading skincare brand for dry and sensitive skin, and other well-known OTC brands such as Fludent, Apobase, Dailycare and Lactocare. As part of the agreement, the Teva sales and marketing team overseeing these brands will join the Trimb organization, further strengthening Trimb’s platform across Sweden, Norway and Denmark. Magnus

Trimb closes its acquisition of skin care brands in northern Europe

Stockholm, January 7, 2019 – Trimb Healthcare AB (“Trimb”) has successfully closed its previously announced acquisition of CCS Healthcare Nordic AB’s (“CCS”) portfolio of skin care products in Sweden, Norway and the UK (“CCS Skincare Brands”). The portfolio includes several well-established and highly recognized brands, including CCS Swedish Formula, Indy Beauty[1], Oliva, Bamse[2], and exclusive rights to DAX and Antibac in the consumer sales channel in Sweden. The CCS Skincare Brands’ sales and marketing organization in Stockholm has also been transferred to Trimb.       For more

Trimb acquires Netherlands-based BioClin BV and strengthens its position in intimate health

Stockholm, December 7, 2018 – Trimb Healthcare (“Trimb”) has completed the acquisition of BioClin BV (“BioClin”), a leading intimate healthcare company based in Delft, Netherlands. The BioClin portfolio includes several well-known, all-natural brands, such as Multi-Gyn, a leading intimate product line treating vaginal discomforts, and Multi-Mam, an innovative product line for breastfeeding mothers. BioClin’s brands are rapidly-growing, and today are sold in pharmacies and drugstores in over 60 countries worldwide. Multi-Gyn and Multi-Mam are established, highly-trusted brands that are

Trimb acquires a portfolio of skin care brands in northern Europe

Stockholm, November 6, 2018 – Trimb Healthcare AB (“Trimb”) has entered into a definitive agreement with CCS Healthcare Nordic AB (“CCS”) to acquire their portfolio of skin care products in Sweden, Norway and the UK (“CCS Skincare Brands”). The portfolio includes several well-established and highly recognized brands, including CCS Swedish Formula, Indy Beauty[1], Oliva, Bamse[2], and exclusive rights to DAX and Antibac in the consumer sales channel in Sweden. The CCS Skincare Brands’ sales and marketing organization in Stockholm will transfer to Trimb as part of the transaction. The closing

Trimb acquires well-established OTC products in Europe

Stockholm, June 28th 2017 – Trimb Healthcare AB (“Trimb”) has acquired a portfolio of well-established European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV (collectively, “J&J”). The products, which include Pevaryl®, Fungoral®, Gyno-Pevaryl® and Epi-Pevaryl®, are based on the anti-fungal substances econazole and ketoconazole and are used to treat common fungal infections of the skin. The acquired territory includes Sweden, Norway, Germany, Switzerland, Austria and other European countries.“This deal with J&J is an important step for Trimb and we continue to

Trimb acquires OTC products from CCS

Stockholm, March 11th 2016 – Trimb Healthcare AB (“Trimb”) has acquired CCS Healthcare AB’s (“CCS”) OTC pharmaceutical products in the Nordics. The products, which include Cortimyk (treatment of foot fungus), Hydrokortison CCS (treatment of mild eczema) and Propyless (treatment of dry skin) among others, are well established in their markets and generate total revenues of approximately €10 million annually.“Trimb already enjoys strong organic sales growth in the Nordics and in other northern European markets. The acquisition of the CCS portfolio strengthens our position in dermatology and

Trimb acquires YouMedical to build North European OTC platform

Trimb Healthcare AB (“Trimb”) today announced that it has signed an agreement to acquire YouMedical Group BV (“YouMedical”), a Dutch OTC company with operations in key European markets. YouMedical has total annual sales of approximately EUR 16 million, with solid growth and leading brands in niche categories. “Our ambition is to build a leading international OTC company, and this acquisition represents an important step toward that goal. YouMedical gives us a stronger North European OTC platform, from which we intend to roll out our pipeline and pursue other strategic acquisitions. In

Trimb and Avista Capital Partners form strategic partnership

Trimb Healthcare AB (“Trimb”) and Avista Capital Partners (“Avista”), a leading private equity firm, today announced that Avista is partnering with the company’s founders and management, as well as its founding investor, HealthCap, to build Trimb into a leading OTC and consumer healthcare company. Avista has made a significant capital commitment to accelerate Trimb’s growth and fund strategic acquisitions within the consumer healthcare industry. “We are excited to be partnering with Avista. They have a well-earned reputation as world-class investors in the healthcare industry. Together

There are no items matching the current filter
There are no more items matching the current filter
Back to top